Outcome of retinoblastoma in east Africa

Bowman, R.J.C; Luande, J.T; Wood, M.; Mafwiri, M.; Luthert, P.

dc.contributor.author	Bowman, R.J.C
dc.contributor.author	Luande, J.T
dc.contributor.author	Wood, M.
dc.contributor.author	Mafwiri, M.
dc.contributor.author	Luthert, P.
dc.date.accessioned	2014-01-16T10:59:09Z
dc.date.available	2014-01-16T10:59:09Z
dc.date.issued	2008
dc.identifier.citation	Bowman, R. J. C., Mafwiri, M., Luthert, P., Luande, J., & Wood, M. (2008). Outcome of retinoblastoma in east Africa. Pediatric blood & cancer, 50(1), 160-162.	en_GB
dc.identifier.other	DOI 10.1002/pbc.21080
dc.identifier.uri	http://hdl.handle.net/123456789/1383
dc.description.abstract	We estimated the proportion of patients reaching a pediatric ophthalmology unit (Comprehensive Community Based Rehabilitation for Tanzania Disability Hospital, CCBRT) or an oncology unit (ORCI) in east Africa and investigated presentation, histology, and treatment outcomes of patients with retinoblastoma. A 5-year retrospective study identified 91 patients, representing approximately 18% of the nationwide total. Mean lag time was 10 months (standard deviation (SD)¼17) and mean follow-up was 8 months (SD¼11, range 0–40, n¼91). Thirty months disease-free survival probability was 0.23 (standard error¼0.07). Outcomes for retinoblastoma in Africa remain poor. The data presented here suggest strategies for improving the outcomes, including encouraging earlier presentation and establishment ofmulti-disciplinary treatment centers. Pediatr Blood Cancer 2008;50:160–162. 2006 Wiley-Liss, Inc	en_GB
dc.language.iso	en	en_GB
dc.publisher	Wiley	en_GB
dc.relation.ispartofseries	Pediatric blood and cancer;50(1), 160-162.
dc.subject	Africa	en_GB
dc.subject	Presentation	en_GB
dc.subject	Outcome;	en_GB
dc.subject	Retinoblastoma	en_GB
dc.title	Outcome of retinoblastoma in east Africa	en_GB
dc.type	Article	en_GB